Sorrento Therapeutics, Inc. SEC Filings

Filed On	Filing
21 Feb 2025	SEC STAFF ACTION
07 Nov 2023	8-K: Departure/Election of Directors or Officers; Compensation; Other Events
03 Nov 2023	8-K: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets
27 Oct 2023	8-K: Departure/Election of Directors or Officers; Compensation
05 Oct 2023	SC 13G/A
05 Oct 2023	Form 4: Sorrento Therapeutics, Inc., 10% owner · Celularity Inc Sold 9,064,539 shares · Sold 6,307,158 shares
05 Oct 2023	8-K: Entry into a Material Definitive Agreement
26 Sep 2023	SC 13D/A
26 Sep 2023	8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more
25 Sep 2023	Form 4: Sorrento Therapeutics, Inc., 10% owner · Scilex Holding Co Sold 60,068,585 shares · Disposed of 4,490,617 Warrants to Purchase Common Stock (Open Market Sale)
13 Sep 2023	8-K: Other Events
28 Aug 2023	8-K: Entry into a Material Definitive Agreement; Other Events
21 Aug 2023	8-K: Regulation FD Disclosure
15 Aug 2023	SC 13D/A
14 Aug 2023	10-Q
10 Aug 2023	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
07 Aug 2023	NT 10-Q
01 Aug 2023	8-K: Regulation FD Disclosure
18 Jul 2023	POS AM
13 Jul 2023	8-K: Regulation FD Disclosure

Comments